The PAZOREAL noninterventional study to assess effectiveness and safety of pazopanib and everolimus in the changing metastatic renal cell carcinoma treatment landscape. Goebell, P.J., Doehn, C., Grüllich, C., Grünwald, V., Steiner, T., Ehneß, R., Welslau, M., 2017. Future Oncol 0(0). doi:10.2217/fon-2017-0083 (epup ahead of print) Abstract Treatment and pattern of bone metastases in 1094 patients with advanced breast cancer – Results from the prospective German Tumour Registry Breast Cancer cohort study. Schröder, J., Fietz, T., Köhler, A., Petersen, V., Tesch, H., Spring, L., Fleitz, A., Jänicke, M., Marschner, N., 2017. Eur J Cancer 79, 139–148. doi:10.1016/j.ejca.2017.03.031… Weiterlesen Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer – results from the MaTox project. Hurtz, H.-J., Tesch, H., Göhler, T., Hutzschenreuter, U., Harde, J., Kruggel, L., Jänicke, M., Marschner, N., TMK-Group (Tumour Registry Breast Cancer), 2017. Breast Cancer Res… Weiterlesen